- Mannelijk
- 28/10/1998
- Gevolgd door 0 mensen
Recente Updates
- Fill Finish Biopharmaceuticals market Share, Growth Analysis by 2035
Given the growing pipeline of biologics, lack of technical expertise, and huge capital investment in the installation of fill / finish equipment, a number of drug manufacturers are turning to contract service providers in order to ensure the development of quality drug products.
This evident surge in the demand for biologics fill and finish services has presented lucrative opportunities for service providers having necessary fill / finish capabilities.
The financial opportunity within the biologics fill finish services market has been analysed across the following segments:
Type of Packaging Container
Ampoules
Cartridges
Syringes
Vials
Type of Biologic
Antibodies
Cell Therapies
Gene Therapies
Oligonucleotides
Proteins / Peptides
Vaccines
Others
Therapeutic Area
Oncological Disorders
Autoimmune Disorders
Infectious Diseases
Cardiovascular Disorders
Other Disorders
Scale of Operation
Preclinical / Clinical
Commercial
Company Size
Large
Mid-sized
Small
Key Geographical Regions
North America
Europe
Asia-Pacific
Middle East and North Africa
Latin America
The “Biologics Fill / Finish Services Market (3rd Edition), 2022 – 2035” report features the following companies, which we identified to be key players in this domain:
AbbVie Contract Manufacturing
Asymchem
BioReliance
Boehringer Ingelheim BioXcellence
Catalent Biologics
Charles River Laboratories
Fareva
Fresenius Kabi
Glaxo SmithKline
Hetero Drugs
Intas Pharmaceuticals
Lonza
Patheon
Pierre Fabre
Recipharm
Samsun Biologics
Syngene
Takara Bio
Wacker Biotech
WuXi AppTec
WuXi Biologics
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Biologics Fill / Finish Service Providers: Market Landscape
5. Company Competitiveness Analysis
6. Biologics Fill / Finish Service Providers in North America
7. Biologics Fill / Finish Service Providers in Europe
8. Biologics Fill / Finish Service Providers in Asia-Pacific
9. Recent Partnerships
10. Recent Expansions
11. Capacity Analysis
12. Demand Analysis
13. Key Performance Indicators for Biologic Manufacturing and Fill / Finish
14. Regional Capability Assessment
15. Biologics Fill Finish Market Sizing and Opportunity Analysis
16. Future Growth Opportunities
17. Case Study: Robotic Systems in Fill / Finish Operations
18. Case Study: Ready-To-Use Packaging Components for Aseptic Fill / Finish
19. Concluding Remarks
20. Executive Insights
21. Appendix 1: Tabulated Data
22. Appendix 2: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/view_document/biologics-fill-finish-services-market/256.html
News article
women's digital health market
Learn from experts: do you know about these emerging industry trends?
Bioavailability Enhancement Technologies
TIL Therapies: A New Paradigm in Cancer Treatment
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#FillFinishManufacturing #FillFinishManufacturingMarket #BiologicsFillFinish #MarketResearch #MarketInsights
0 0 Reacties 0 Aandelen - Antibody Drug Conjugate market Size, Share, Trends by 2035
The potential of antibody drug conjugates for the treatment of various disease indications, including cancer, is being slowly recognized in the pharmaceutical sector. Specifically, the success of these products can be attributed to their ability to effectively identify and eliminate diseased cells, along with low risk of side effects.
The financial opportunity within the antibody drug conjugate market has been analyzed across the following segments:
Target Disease Indication
Acute Lymphoblastic Leukemia
Breast Cancer
B-Cell Lymphoma
Cervical Cancer
Gastric Cancer
Lung Cancer
Multiple Myeloma
Renal Cancer
Other Target Disease Indications
Therapeutic Area
Hematological Cancer
Solid Tumor
Linker
Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (Acbut)
Maleimide
Maleimidocaproyl
Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate
Tetrapeptide-Based Linker
Valine-Alanine
Valine-Citrulline
Other Linkers
Payload
DM1
DM4
Duocarmycin
Monomethyl auristatin E (MMAE)
Monomethyl auristatin F (MMAF)
Ozogamicin
SG3199
SN-38 / Irinotecan
Other Payloads
Target Antigen
BCMA (TNFRSF17 / BCM)
CD19
CD22
CD30
CD79b
CEACAM5
HER-2 (ERBB2)
Nectin 4
Tissue factor
TROP-2
Other Target Antigen
Key Geographical Regions
North America
Europe
Asia-Pacific and Rest of the World
The Antibody Drug Conjugate Market (7th Edition), 2023-2035 report features the following companies, which we identified to be key players in this domain:
ADC Therapeutics
Astellas Pharma
AstraZeneca
Byondis
Daiichi Sankyo
Genentech
Gilead Sciences
ImmunoGen
Pfizer
RemeGen
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape
5. Target Competitiveness Analysis
6. Company and Drug Profiles
7. Clinical Trial Analysis
8. Key Opinion Leaders
9. Combination Therapies
10. Partnerships and Collaborations
11. Funding and Investment Analysis
12. Patent Analysis
13. Academic Grants Analysis
14. Key Commercialization Strategies
15. Promotional Analysis
16. Success Protocol Analysis
17. Novel Conjugation and Linker Technology Platforms
18. Assessment of Non-Clinical Data First in Human Dosing
19. Cost Price Analysis
20. Case Study 1: Contract Manufacturing of Antibody-Drug Conjugates
21. Case Study 2: Companion Diagnostics for Antibody-Drug Conjugate Therapeutics
22. SWOT Analysis
23. Market Sizing and Opportunity Analysis
24. Executive Insights
25. Conclusion
26. Appendix 1: Tabulated Data
27. Appendix 2: List of Companies and Organizations
To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/view_document/antibody-drug-conjugates-market/270.html
Learn from experts: do you know about these emerging industry trends?
Digital Therapies: The “Digital Pills” of current generation
Medical Device Coatings and Modification Technologies
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#ADCMarket #antibodydrugconjugate #antibodydrugconjugatemarket #MarketResearch #MarketInsights
0 0 Reacties 0 Aandelen - Intracellular Drug Delivery market Growth Analysis and Forecast by 2035
The growing demand for novel drugs that can acts as potential treatments for previously untreatable intracellular targets has resulted in an adjacent and urgent need for efficient delivery systems that facilitate intracellular transport of therapeutics across the cytosol
The financial opportunity within non-viral drug delivery systems market has been analyzed across the following segments:
Type of Molecule
Small Molecule
Biologic
Type of Biologic
Antibodies
DNA
RNA
Proteins / Peptides
Type of Intracellular Drug Delivery Technologies
Cell Penetrating Peptides
Extracellular Vesicles
Oligonucleotides
Nanoparticles
Polymers
Target Therapeutic Area
Infectious Diseases
Oncological Disorders
Genetic Disorders
Neurological Disorders
Hepatic Disorders
Cardiovascular Disorders
Other Disorders
Type Of Payment Model
Upfront Payments
Milestone Payments
Key Geographical Regions
North America
Europe
Asia
Latin America
Middle East and North Africa (MENA)
Rest of the world
The Non-Viral Drug Delivery Systems Market: Focus on Intracellular Technologies and Biologics (2nd Edition), 2022-2035, report features the following companies, which we identified to be key players in this domain:
Alnylam Pharmaceuticals
AstraZeneca
Biond Biologics
Code Biotherapeutics
Eli Lilly
Merck
Novartis
Roche
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape
5. Key Insights
6. Company Competitiveness Analysis
7. Company Profiles
8. Patent Analysis
9. Partnerships and Collaborations
10. Opportunity Assessment Framework
11. Market Forecast
12. Conclusion
13. Executive insights
14. Appendix I: Tabulated data
15. Appendix II: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/non-viral-drug-delivery-systems-market.html
News article
AI-based Digital Pathology Market
Learn from experts: do you know about these emerging industry trends?
Antiviral Drugs Development: Are we Prepared for the Next Viral Pandemic?
Exploring How Artificial Intelligence Is Transforming Digital Pathology
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#nonviraldrugdeliverysystemmarket #Intracellularbiologics #intracellulardelivery #MarketResearch #MarketInsights
0 0 Reacties 0 Aandelen - Women Digital Health market Share, Growth Analysis by 2035
The growing popularity of digital solutions has enabled the development of technological remedies, such as mobile apps, software, wearable devices and diagnostic tools that exclusively aid in improving female health and wellness.
Owing to the increased adoption rate of digital solutions and rise in the demand for remote healthcare services, the companies involved in the women’s digital health domain have witnessed a surge in the investment activity. Further, taking into consideration both the historical and modern scenarios, we expect the women’s digital health market to offer numerous lucrative investment opportunities.
The financial opportunity within the women’s digital health market has been analyzed across the following segments:
Type of Solution
Applications / Software
Devices
Services
Therapeutic Application Area
Fetal Health
General Wellness
Menstrual Cycle
Pelvic Care
Reproductive Health / Fertility
Key Geographical Regions
North America
Europe
Asia-Pacific
Latin America
Middle East and North Africa
The Investor Series: Opportunities in Women’s Digital Health Market, features detailed profiles of the key public ventures engaged in the development of women’s digital health solutions; each profile features a brief overview of the company, details on its management team, insights from its balance sheet (if available), details on its product / service portfolio, recent developments and key financial details (including company investment highlights, company fundamental and company technical analysis). A detailed analysis of the women's digital health funding and women's digital health investment activity that has taken place, since 2011.
Table of Contents
Excel Deliverables
1. Innovators and Product Dataset
2. Funding and Investment Analysis
3. Fundamental and Technical Financial Analysis
4. Market Forecast and Opportunity Analysis
5. Return on Investment
PowerPoint Deliverable
1. Context
2. Project Objectives
3. Project Approach
4. Executive Summary
Section I: Introduction to Women’s Digital Health Solutions and Innovator Landscape
5. The Women’s Digital Health Market
6. Women’s Digital Health: Innovator Landscape
7. Women’s Digital Health: Product Landscape and Company Health Indexing
8. Value Proposition Analysis
9. Company Competitiveness Analysis
Section II: Analysis of Investments
10. Funding and Investment Analysis
Section III: Financial Analysis of Key Public Ventures
11. Financial Analysis of Public Ventures
12. Company Profiles of Public Ventures
Section IV: Market Forecast and Opportunity Analysis
13. Market Forecast and Opportunity Analysis
Section V: Key Acquisition Targets, Business Risk Assessment and Return on Investments
14. Key Acquisition Targets
15. Business Risk Assessment
16. Return on Investments
17. Conclusion
18. Appendices
Get more details on the report https://www.rootsanalysis.com/reports/opportunities-in-women-digital--health-market.html
Learn from experts: do you know about these emerging industry trends?
mRNA Synthesis: Manufacturing Process of Modern Revolutionary Molecule
TIL Therapies: A New Paradigm in Cancer Treatment
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#WomensDigitalHealth #womensdigitalhealthsolutions #digitalhealth #MarketResearch #MarketInsights
0 0 Reacties 0 Aandelen - Analysis of modular manufacturing market Strategies and Forecasts to 2035
Modular facilities can be an effective way for drug developers and manufacturers to reduce costs, minimize delays, and expedite time-to-market, by utilizing the available infrastructure while operating in accordance with the standard GMP guidelines
The financial opportunity within modular facilities market has been analyzed across the following segments:
Size of Facility
Small Plants
Mid-sized Plants
Large Plants
Very Large Plants
Type of Industry Served
Pharmaceutical
Biotechnology
Type of Modular Construct
Hybrid Skid Modular Constructs
Plug-and-Play Modular Constructs
Skid-Mounted Modular Constructs
Truckable Modular Constructs
Others Modular Constructs
Type of Construction Component
Process Equipment
Base Building
Mechanical, Electrical and Plumbing System
Process Commodities
Other Construction Components
Type of Facility
Manufacturing
Aseptic Filling
Research and Development
Others
Scale of Operation
Clinical
Commercial
Type of Product
Cell and Gene Therapies
Vaccines
Biosimilars
Monoclonal Antibodies
Advanced Pharmaceuticals
Sterile Products
Viral Vectors
Other Products
Type of Expansion
New Facilities
Facility Expansions
Planned Expansions
Type of Modular Construction
Relocatable
Permanent
Type of Material
Steel
Wood
Concrete
Key Geographical Regions
North America
Europe
Asia
Middle East and North Africa (MENA)
Rest of the world
The Modular Facilities in the Pharmaceutical and Biotech Market, 2023-2035, report features the following companies, which we identified to be key players in this domain:
Cytiva
G-CON Manufacturing
Germfree
IPM Technologies
KeyPlants
ModuleCo Pharma
NNE
Pharmadule
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape: Modular Facility Manufacturers
5. Market Landscape: Modular Cleanroom Providers
6. Modular Facility Manufacturers: Company Competitiveness Analysis
7. Company Profiles
8. Partnerships and Collaborations
9. Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry
10. Facility Construction Trends in the Pharmaceutical Industry
11. Cost, Time Optimization Framework
12. Market Forecast
13. Prevalent and Emerging Trends
14. Future Growth Opportunities
15. Conclusion
16. Executive insights
17. Appendix I: Tabulated data
18. Appendix II: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/modular-manufacturing-market/178.html
Learn from experts: do you know about these emerging industry trends?
Investment Opportunities in Women’s Digital Health
Genotoxicity Testing: Unlocking the Future Safety Assessment Opportunities
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#modularcleanroom #modularcleanroommanufacturers #modularconstructionmarket #MarketResearch #MarketInsights
0 0 Reacties 0 Aandelen - Opportunities in RNA Therapeutics market 2023 – Industry Growth by 2035
RNA therapies have emerged as a promising treatment modality, with the potential to target and alter genes, modulate protein functions and broaden the range of druggable targets, thereby paving way for new avenues in disease diagnosis and treatment.
With rise in government initiatives for early commercialization of pipeline therapies and active involvement of RNA therapeutics investors, we anticipate a variety of novel RNA based therapeutics to be developed, presenting lucrative opportunities for both short- and long-term investors.
The financial opportunity within the RNA therapeutics market has been analyzed across the following segments:
Type of Therapy
mRNA Vaccines and Therapeutics
RNAi Therapeutics
RNA Aptamers
Therapeutic Area
Infectious Diseases
Genetic Disorders
Haematological Disorders
Metabolic Disorders
Ocular Disorders
Oncological Disorders
Renal Disorders
Route of Administration
Intradermal
Intramuscular
Intravenous
Intravitreal
Ophthalmic
Subcutaneous
Key Geographies
North America
Europe
Asia-Pacific
Middle East and North Africa
Latin America
The Investor Series: Opportunities in the RNA Therapeutics Market (mRNA Therapeutics and Vaccines, RNAi Therapeutics, and RNA Aptamers), detailed profiles of key public ventures engaged in the development of RNA therapeutics; each profile features a brief overview of the company, along with information on its management team, insights from its balance sheet (if available), as well as details related to its product portfolio, recent developments and key financials (including company investment highlights, company fundamental and company technical analysis).
Arcturus Therapeutics
Ascletis Pharma
Avidity Biosciences
BioNtech
CanSino Biologics
Gritstone bio
IVERIC bio
Moderna
Phio Pharmaceuticals
Vir Biotechnology
Table of Contents
Excel Deliverables
1. Innovators and Products Dataset
2. RNA therapeutics Funding and Investment Analysis
3. Company Valuation Analysis
4. Fundamental Financial Analysis
5. Technical Financial Analysis
6. Business Risk Analysis
7. Market Forecast and Opportunity Analysis
8. Return on Investment
PowerPoint Deliverable
1. Context
2. Project Approach
3. Project Objective
4. Executive Summary
Section I: Introduction to RNA Therapeutics and Innovators Landscape
5. The RNA Therapeutics Market
6. RNA Therapeutics: Innovators Landscape
7. RNA Therapeutics: Products Landscape and Company Health Indexing
8. Value Proposition Analysis
9. Company Competitiveness Analysis
Section II: Analysis of RNA therapeutics Investment and Company Valuation
10. Funding and Investment Analysis
11. Company Valuation Analysis
Section III: Financial Analysis and Assessment of Business Risks
12. Financial Analysis of Public Ventures
13. Company Profiles of Public Ventures
14. Business Risk Assessment
Section IV: Market Forecast and Opportunity Analysis
15. Market Forecast and Opportunity Analysis
Section V: Analysis of Returns on Investment and Key Acquisition Targets
16. Analysis of Return on Investment
17. Key Acquisition Targets
18. Conclusion
19. Appendices
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/opportunities-in-rna-therapeutics-market.html
Learn from experts: do you know about these emerging industry trends?
T-cell Immunotherapies: The Future of Modern Cancer Treatments
Monkeypox: Disease Overview, Transmission and Diagnosis
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#RNATherapeuticsFumding #RNATherapeuticsInvestment #RNATherapeuticsInvestors #Marketresearch #MarketInsights
0 0 Reacties 0 Aandelen - Dental 3D Printing market Growth Analysis and Forecast by 2035
The popularity of 3D printing technology within the dental industry can be attributed to its ability to print high quality / accurate dental products, including crowns, bridges, dentures, dental implants and surgical guides.
Driven by the overall growth of the additive manufacturing (3D printing) industry, and wide adoption of 3D printers in the dental sector, the dental 3D printing market is anticipated to witness a steady growth in the foreseen future.
The financial opportunity within the SMOs market has been analyzed across the following segments:
Type of Printing Technology
VAT Polymerization Technology
Powder Bed Fusion Technology
Polyjet Technology
Metal Extrusion Technology
Other Technologies
Application Area
Prosthodontics
Orthodontics
Dental Implants
Other Applications
Type of Printing Material
Resins
Plastics
Metals
Metals
Other Material
Key Geographical Regions
North America
Europe
Asia-Pacific
Latin America
Middle East and North Africa
Rest of the World
The Dental 3D Printing Market, 2022 – 2035 report studies dental 3D printers manufacturers in detail and features the following companies, which we identified to be key players in this domain:
3D Systems
Asiga
BEGO
Carbon
Digital Wax Systems (DWS)
Formlabs
Prodways
Rapid Shape
SprintRay
Stratasys
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape
5. Product Competitive Analysis
6. Company Profiles
7. Partnerships and Collaborations
8. Patent Analysis
9. Bowman Clock Pricing
10. Market Forecast and Opportunity Analysis
11. Concluding Remarks
12. Executive Insights
13. Appendix 1: Tabulated Data
14. Appendix 2: List of Companies And Organizations
Get more details on the Dental 3D Printing Market report https://www.rootsanalysis.com/reports/dental-3d-printing-market.html
Learn from experts: do you know about these emerging industry trends?
Digital Therapies: The “Digital Pills” of current generation
Medical Device Coatings and Modification Technologies
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#3dprinteddentalimplants #3d printingdentalimplants #dental3dprinting #MarketResearch #MarketInsights
0 0 Reacties 0 Aandelen - Bacteriophage therapy market Growth Analysis and Forecast by 2035
With the ever-increasing burden of antimicrobial resistance, the focus of the research community has shifted towards the development of alternatives for the treatment of infectious diseases.
One of such alternatives is bacteriophage therapeutics. The innovators suggests that the success of these therapies lies in the effectiveness of phages to target the desired bacterial strains.
The financial opportunity within the bacteriophage therapeutics market has been analyzed across the following segments:
Type of Therapeutic Area
Infectious Diseases
Oncological Disorders
Other Disorders
Distribution by Route of Administration
Oral Route
Rectal Route
Intravesical Route
Topical Route
Key Geographical Regions
North America
Europe
Asia-Pacific
Latin America
Middle East and North Africa
The “Bacteriophage Therapies Market, 2022-2035” report features the following companies, which we identified to be key players in this domain:
Adaptive Phage Therapeutics
ContaFect
Eliava BioPreparations
Micreos
NPO Microgen
Phagelux
Pherecydes Pharma
Table of Content
1. PREFACE
2. EXECUTIVE SUMMARY
3. INTRODUCTION
4. BACTERIO-PHAGE THERAPY: MARKET LANDSCAPE
5. BACTERIO-PHAGE THERAPEUTICS: DEVELOPER LANDSCAPE
6. COMPANY AND DRUG PROFILES
7. CLINICAL TRIAL ANALYSIS
8. PATENT ANALYSIS
9. PUBLICATION BENCHMARKING ANALYSIS
10. ACADEMIC GRANTS ANALYSIS
11. FUNDING AND INVESTMENT ANALYSIS
12. PARTNERSHIPS AND COLLABORATIONS
13. START-UP HEALTH INDEXING
14. MARKET FORECAST AND OPPORTUNITY ANALYSIS
15. CONCLUSION
16. EXECUTIVE INSIGHTS
17. APPENDIX I: TABULATED DATA
18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
For additional details, please visit https://www.rootsanalysis.com/reports/bacteriophage-therapy-market.html
Learn from experts: do you know about these emerging industry trends?
Rare Kidney Disorders: Future Miracle Drugs
Smart pharmaceutical and healthcare labels: Lets trace medicines from its origin
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#bacteriophagetherapeutics #bacteriophagetherapies #bacteriophagemarket #Marketresearch #MarketInsights
0 0 Reacties 0 Aandelen - Latest news on Exosome Therapeutics market Research Report by 2035
Driven by the development of novel platforms and advanced technologies along with consistent efforts of the stakeholders in research and development of exosome therapeutics which is set to see some FDA approved therapies in this decade
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):
Type of Therapeutic
Allogeneic Therapy
AutologousTherapy
Target Indication(s)
Degenerative Meniscal Injury
Dystrophic Epidermolysis Bullosa
Fistula Perianal
Retinitis Pigmentosa
Therapeutic Area
Dermatological Disorders
Muscoskeletal Disorders
Ophthalmic Diseases
Rectal Disorders
Route of Administration
Fistula Tract
Intra-articular
Intra-ocular
Geography
North America
Europe
Asia-Pacific and Rest of the World
The Exosome Therapeutics Market, 2022-2040 report features the following companies, which we identified to be key players in this domain:
Codiak BioSciences
Coya Therapeutics
Curexsys
EV Therapeutics
Evox Therapeutics
SHIFTBIO
AEGLE Therapeutics
AVEM Healthcare
Cellular Biomedicine Group
OBCTCD24
ReNeuron
Stem Cell Medicine
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape
5. Company Profiles
6. Drug Profiles
7. Clinical Trial Analysis
8. Academic Grants Analysis
9. Global Event Analysis
10. Partnerships and Collaborations
11. Funding and Investments
12. Start-up Health Indexing
13. Case Study: Exosome Development and Manufacturing Service Providers
14. Drug Failure Analysis
15. Market Forecast
16. Executive Insights
17. Appendix 1: Tabulated Data
18. Appendix 2: List of Companies and Organizations
Key Questions Answered
Who are the leading industry and non-industry players engaged in the development of exosome therapy?
Which are the key drugs being developed across early and late stages of development?
What are the key agendas being discussed in various global events / conferences related to exosomes?
What kind of partnership models are commonly adopted by industry stakeholders?
Which are the leading funding institutes / centers supporting the research related to exosome therapies?
Which geographies are the most active in conducting clinical trials related to exosome therapeutics?
How is the current and future market opportunity, related to exosome therapies likely to be distributed across key market segments?
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/exosome-therapeutics-market.html
News article
Smart Pharmaceutical and Healthcare Labels Market
Learn from experts: do you know about these emerging industry trends?
Unlocking the Potential of Digital Twins in Healthcare: Benefits, Challenges and Opportunities
Digital Therapies: The “Digital Pills” of current generation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#exosometherapy #exosomediagnostics #exosomecompanies #MarketResearch #MarketInsights
0 0 Reacties 0 Aandelen - Filtration market Analysis and Trends by 2023-2035
The biopharmaceutical filtration market has been growing rapidly in recent years, driven by the increasing demand for biologics, as well as advances in filtration technologies.
It is a critical step in the manufacturing process of biopharmaceutical products, and its applications are essential in ensuring the safety, quality, and efficacy of the final product. The financial opportunity within the biopharmaceutical market has been analyzed across the following segments:
Type of Filtration System
Depth Filtration System
Tangential Flow Filtration Systems
Membrane Filtration System
Other Filtration Systems
Type of Filter (based on use)
Disposable / Single-use Filters
Reusable / Multi-use Filters
Type of Assembly
Capsules
Cartridges
Others
Type of Drug Product
Antibodies
Vaccines
Recombinant Proteins
Cell Therapies
Gene Therapies
Oligonucleotides
Others
Company Size
Small / Mid-sized
Large
Key Geographical Regions
North America
Europe
Asia-Pacific
Rest of the World
The “Global Filtration Market (Focus on Biologics Manufacturing), 2023 – 2035” report features the following companies, which we identified to be key players in this domain:
Asahi Kasei
Cobetter Filtration
Corning
Merck
Pall
Parker Hannifin
Sartorius
Thermo Fisher Scientific
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Biopharmaceutical Filtration: Market Landscape
5. Company Competitiveness Analysis
6. Suppliers Headquartered in North America: Company Profiles
7. Suppliers Headquartered in Europe and Asia-Pacific: Company Profiles
8. Recent Developments
9. Global Events Analysis
10. Biopharmaceutical Filtration: Market Forecast and Opportunity Analysis
11. Conclusion
12. Executive Insights
13. Appendix 1: Tabulated Data
14. Appendix 2: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/global-filtration-market.html
Learn from experts: do you know about these emerging industry trends?
TCR Therapies: An Emerging Therapeutic Modality
Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#membranefiltrationmarket #membranefiltrationsystem #pharmaceuticalfiltrationmarket #MarketResearch #MarketInsights
0 0 Reacties 0 Aandelen
Meer Verhalen